文献速递瓣膜病与结构性心脏病

恶性心包积液:心包穿刺与心包开窗术的趋势与结局

Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes.
PubMed 文献 · Heart · 2024-05-23

本研究回顾性分析2003—2022年765例接受心包引流的癌症患者(平均年龄58.4岁,男性395例),比较心包穿刺与心包开窗术的结局。心包穿刺占83.5%、开窗术占16.5%;两组全因死亡无差异(log-rank p=0.226),开窗术组恶性心包积液复发率更低(6.3% vs 18.0%,log-rank p=0.001)。

要点

  • 心包开窗术与心包穿刺的全因死亡无差异,但复发率更低(6.3% vs 18.0%)。
  • 第二时期开窗术的复发优势更明显(1.3% vs 18.1%,log-rank p=0.005)。
  • 多因素分析示开窗术与更低复发相关(HR 0.31,95%CI 0.15–0.63,p=0.001)。

核心结论

  • 对恶性心包积液行心包引流者,心包开窗术的死亡结局与心包穿刺相当,且与更低的积液复发相关。

研究设计与样本

  • 回顾性分析2003—2022年765例连续癌症患者(平均年龄58.4岁,男性395例),均接受心包引流,按引流方式与时期分组比较。

主要发现

  • 心包穿刺639例(83.5%),心包开窗术126例(16.5%),两组年龄、性别、转移或复发比例及化疗状态无差异。
  • 两组全因死亡无差异(log-rank p=0.226),各时期均如此。
  • 开窗术组复发率低于穿刺组(6.3% vs 18.0%,log-rank p=0.001)。
  • 第二时期开窗术优势更显著(18.1% vs 1.3%,log-rank p=0.005)。
  • 多因素分析:开窗术与更低复发相关(HR 0.31,95%CI 0.15–0.63,p=0.001);年轻、转移或复发癌、心包液恶性细胞阳性与复发增加相关。

临床怎么用

  • 对恶性心包积液需引流者,可结合复发风险与预后权衡选择心包开窗术以降低复发。

局限性

  • 为单中心回顾性研究,样本来自2003—2022年连续病例,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Malignant pericardial effusion (MPE) in patients with cancer is associated with poor prognosis. This study aimed to compare clinical outcomes in patients with cancer who underwent pericardiocentesis versus pericardial window formation. METHODS: In the present study, 765 consecutive patients with cancer (mean age 58.4 years, 395 men) who underwent pericardial drainage between 2003 and 2022 were retrospectively analysed. All-cause death and MPE recurrence were compared based on the drainage method (pericardiocentesis vs pericardial window formation) and time period (period 1: 2003-2012; period 2: 2013-2022). RESULTS: Pericardiocentesis was performed in 639 (83.5%) patients and pericardial window formation in 126 (16.5%). There was no difference in age, sex distribution, proportion of metastatic or relapsed cancer, and chemotherapy status between the pericardiocentesis and pericardial window formation groups. Difference was not found in all-cause death between the two groups (log-rank p=0.226) regardless of the period. The pericardial window formation group was associated with lower MPE recurrence than the pericardiocentesis group (6.3% vs 18.0%, log-rank p=0.001). This advantage of pericardial window formation was more significant in period 2 (18.1% vs 1.3%, log-rank p=0.005). In multivariate analysis, pericardial window formation was associated with lower MPE recurrence (HR: 0.31, 95% CI: 0.15 to 0.63, p=0.001); younger age, metastatic or relapsed cancer, and positive malignant cells in pericardial fluid were associated with increased recurrence. CONCLUSION: In patients undergoing pericardial drainage for MPE, pericardial window formation showed mortality outcomes comparable with pericardiocentesis and was associated with lower incidence of MPE recurrence.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Lee J, Kim K, Gwak SY, et al. Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes. Heart. 2024. PMID: 38302262. doi:10.1136/heartjnl-2023-323542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。